Bruker's Q3 Revenues Rise 22 Percent as Profit Increases by a Third | GenomeWeb
NEW YORK (GenomeWeb News) — Bruker Biosciences’ third-quarter revenue increased 22 percent as income jumped by a third, the company said today.
Receipts for the three months ended Sept. 30 rose to $104.8 million from $85.9 million year over year. Product revenues were up 22 percent to $50.1 million and receipts from the company’s services business tallied $8 million, a third more than the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.